1st Quarter - Report

PLASTICS INDUSTRY ASSOCIATION, INC. for PLASTICS INDUSTRY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Clean Air and Water (quality) CAW

Congressional oversight of EPA (e.g. Clean Water Rule, Clean Power Plan, Clean Air Act) EPA - Marine Debris

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
SUZANNE MORGAN —

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); President of the U.S.; SENATE; U.S. Trade Representative (USTR); Surface Transportation Board (STB)

Transportation TRA

Open Competition for plastic material in infrasture projects (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
PATRICIA DAVITT LONG —
SUZANNE MORGAN —

Contacted: HOUSE OF REPRESENTATIVES; President of the U.S.; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Surface Transportation Board (STB); SENATE

Energy/Nuclear ENG

Energy conversion technologies (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
SUZANNE MORGAN —

Contacted: HOUSE OF REPRESENTATIVES; President of the U.S.; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Surface Transportation Board (STB)

Taxation/Internal Revenue Code TAX

R&D Amortization (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
SUZANNE MORGAN —

Contacted: President of the U.S.; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Surface Transportation Board (STB); Environmental Protection Agency (EPA)

Labor Issues/Antitrust/Workplace LBR

Worforce Development (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
PATRICIA DAVITT LONG —
SUZANNE MORGAN —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Surface Transportation Board (STB); SENATE; President of the U.S.; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA)

Food Industry (safety, labeling, etc.) FOO

FDA Funding including the Food Contact Notification Program / FY 2019 and FY 2020 House and Senate Appropriations Legislation

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —

Contacted: Surface Transportation Board (STB); Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; President of the U.S.; Environmental Protection Agency (EPA)

Trade (domestic/foreign) TRD

The United States-Mexico-Canada Agreement (USMCA)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
PATRICIA DAVITT LONG —
SUZANNE MORGAN —

Contacted: Surface Transportation Board (STB); Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; President of the U.S.; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Railroads RRR

STB Nominations Issues regarding systemic delays with rail shipping (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —

Contacted: U.S. Trade Representative (USTR); President of the U.S.; SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Surface Transportation Board (STB)

Environment/Superfund ENV

Frank R. Lautenberg Chemical Safety for the 21st Centrury Act implementation Educational outreach on the safe storage and handling of organic perozides (no bill) Education on need for recycling and energy conversion infrastructure (no bill)

LobbyistCovered position, as disclosed
JOHN SCOTT DEFIFE —
JOHN GRANT —
PATRICIA DAVITT LONG —
SUZANNE MORGAN —

Contacted: President of the U.S.; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); SENATE; Surface Transportation Board (STB); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.